Literature DB >> 7095859

Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.

P Koskela, E Herva.   

Abstract

Live attenuated Francisella tularensis vaccine induced long-lasting humoral and cell-mediated immune responses in all 13 subjects studied. Lymphocyte blast transformation reactivity to F. tularensis appeared 2 weeks after vaccination in most subjects and remained unchanged for up to 1.5 years. Similarly, in most recipients, antibodies against F. tularensis were detectable by both the enzyme-linked immunosorbent assay (ELISA) and the agglutination method from 2 weeks after vaccination, although diagnostically significant agglutination titers (greater than or equal to 80) were not detectable until 4 weeks after vaccination. Maximal agglutination titers of 80 to 2,560 appeared at 4 to 8 weeks, and in spite of decreasing tendency, titers as high as 320 were still present 1.5 years after vaccination. ELISA showed the simultaneous, but not parallel, appearance of different immunoglobulin classes, immunoglobulin M (IgM) reaching individual maximal values 1.8 months after vaccination on average, at the same time as agglutinating antibodies, 1 week earlier than IgA, and about 1 month earlier than IgG. All of these immunoglobulin classes persisted in significant amounts up to 1.5 years, with IgG generally dominant. Long-lasting IgA and IgM responses after vaccination, as also after infection, suggested that the serodiagnosis of tularemia generally requires two consecutive serum samples with a significant increase in the titer.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7095859      PMCID: PMC551428          DOI: 10.1128/iai.36.3.983-989.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Public Health Weekly Reports for JUNE 25, 1926.

Authors: 
Journal:  Public Health Rep       Date:  1926-06-25       Impact factor: 2.792

2.  Determination of virus-specific IgM antibodies by using ELISA: elimination of false-positive results with protein A-Sepharose absorption and subsequent IgM antibody assay.

Authors:  P O Leinikki; I Shekarchi; P Dorsett; J L Sever
Journal:  J Lab Clin Med       Date:  1978-12

3.  Airborne tularemia in Sweden.

Authors:  S Dahlstrand; O Ringertz; B Zetterberg
Journal:  Scand J Infect Dis       Date:  1971

4.  Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans.

Authors:  T P Monath
Journal:  Am J Epidemiol       Date:  1971-02       Impact factor: 4.897

5.  The tularemia skin test. 325 skin tests in 210 persons: serologic correlation and review of the literature.

Authors:  T M Buchanan; G F Brooks; P S Brachman
Journal:  Ann Intern Med       Date:  1971-03       Impact factor: 25.391

6.  Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis.

Authors:  A Tärnvik; S E Holm
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

7.  Enzyme-linked immunosorbent assay for immunological diagnosis of human tularemia.

Authors:  H E Carlsson; A A Lindberg; G Lindberg; B Hederstedt; K A Karlsson; B O Agell
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

8.  Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay.

Authors:  E M Salonen; A Vaheri; J Suni; O Wager
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

9.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

10.  Immunity against tularemia: passive protection of mice by transfer of immune tissues.

Authors:  W P ALLEN
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

Authors:  A Tärnvik; M Eriksson; G Sandström; A Sjöstedt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

2.  Kinetics of the immune response associated with tularemia: comparison of an enzyme-linked immunosorbent assay, a tube agglutination test, and a novel whole-blood lymphocyte stimulation test.

Authors:  Henrik Eliasson; Per Olcén; Anders Sjöstedt; Margareta Jurstrand; Erik Bäck; Sören Andersson
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

3.  Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; K T McKee; G Sandstrom; L L Pratt; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

4.  Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination.

Authors:  R Karttunen; G Andersson; H P Ekre; K Juutinen; H M Surcel; H Syrjälä; E Herva
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

5.  Protein heterogeneity of Francisella tularensis: detection of proteins with antigenic determinants.

Authors:  J Stulik; J Cerna; H Kovarová; A Macela
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

6.  Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.

Authors:  Katharina Richard; Barbara J Mann; Lenea Stocker; Eileen M Barry; Aiping Qin; Leah E Cole; Matthew T Hurley; Robert K Ernst; Suzanne M Michalek; Daniel C Stein; Philip Deshong; Stefanie N Vogel
Journal:  Clin Vaccine Immunol       Date:  2013-12-18

Review 7.  Tularemia vaccines.

Authors:  Daniela Putzova; Iva Senitkova; Jiri Stulik
Journal:  Folia Microbiol (Praha)       Date:  2016-05-19       Impact factor: 2.099

8.  Humoral immunity against Francisella tularensis after natural infection.

Authors:  P Koskela; A Salminen
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

9.  Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans.

Authors:  A Sjöstedt; M Eriksson; G Sandström; A Tärnvik
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 10.  Vaccines against tularemia.

Authors:  Eileen M Barry; Leah E Cole; Araceli E Santiago
Journal:  Hum Vaccin       Date:  2009-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.